Talking Biotech with Dr. Kevin Folta

There is a vanilla crisis.  The familiar flavor agent is a mixture of chemicals from an orchid- and there’s not enough being produced to satisfy demand.  But Dr. Alan Chambers knows that crisis and opportunity travel together.  He is currently engaging in breeding of vanilla orchids, hoping to improve yields and product quality.  In this episode he covers vanilla’s natural history, its current challenges in cultivation and future outlook.# COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

In framing effective discussions about any subject it is important to understand human psychology, and the mistakes we make in debate.  It also is important to understand how ingrained human tendencies shape our perceptions and skew our willingness to accept new information.  In this episode Itamar Schatz discusses these concepts, concepts that are the basis of his website Effectiviology. We discuss critical thinking and the issues that cloud discussion like confirmation bias, logical fallacy, and other aspects of logic and reason that sometimes are lost in contentious discussion. The goal is to understand these concepts to make us better communicators about science. Visit Itamar’s website:  effectiviology.com# COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

The herbicide glyphosate has been in use for over 40 years.  It is non-selective (kills all plants), it is inexpensive and has extremely low toxicity.  These attributes made it an important tool for municipalities, farmers, and homeowners. Use increased starting in 1996 with the advent of glyphosate-tolerant (marketed under the brand name “Roundup Ready”) crops, which have expanded in acreage ever since. Rob Saik (@rsaik) is an agronomist with significant experience and accolades in Canadian agriculture.  Along with his collaborator Chris Dufault, they compiled and analyzed Ontario government data on glyphosate use, and reported these trends. Rob describes the report and its findings.Download the report at :  robertsaik.com  # COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

This last week podcast host Kevin Folta found himself in a difficult predicament.  There was palpable outrage by those affiliated with a science website where he participated in some of their activities.  Turns out that Folta also did paid work outside of his university job, which is normal.  He was retained by a law firm as a special matters expert, someone to analyze some data in a private mediation.  He was bound my confidentiality to not discuss the details of the case.  The folks from the science website used public records requests to obtain Folta’s confidential internal university documents requesting permission to perform outside work.  These are forms where universities approve participation in paid activities beyond the normal job description. Those requesting the documents read details about the confidential work, and then posted a damaging website where confidentiality was broken, and Folta was accused of being non-transparent. The instance triggered the need for an important discussion.  Scientists typically have non-disclosure agreements.  Such agreements demand confidentiality.  At the same time, we expect them to be completely transparent.Can we simultaneously honor confidentiality and transparency?   Probably not.  So how can we be trusted communicators in a space where collaborators don’t want their information shared?    This discussion between Drs. Paul Vincelli and Kevin Folta hopefully will seed a much needed conversation.# COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

Malaria is a tremendous world health problem, affecting the lives of hundreds of millions of people in the developing (and industrialized) world. One of the most effective therapies is derived from a natural compound produced in the plant Artemisia annua.  In this week’s podcast Dr. Ian Graham from the University of York describes the problem of malaria, historical treatments, the use of artemesia and the isolation of artemisinin.  Breeding and engineering of plants and microbes to enhance production is discussed.Link to Prof. Graham’s website.# COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

The chicken is by far the most abundant animal farmed on earth, grown for meat and eggs.  But where did it come from?  What kinds of birds were domesticated?  When?  Where?  What were the traits that came from wild jungle fowl that give us today’s familiar bird?  These questions and more are answered by Dr. Greger Larson from Oxford University.  Dr. Larson combines data from genomics, archaeology, and anthropology to reconstruct the ancient history of various animals, illuminating how they became part of agriculture.  This episode of explores the fascinating history of domestic chickens.Follow Prof Larson:  @Greger_Larson # COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

Plant disease resistance is a complicated arms race between the plant and pathogens.  Bacteria, viruses and fungi evolve in lock-step with plants, creating new ways to overcome new disease resistance strategies.  Resistance to disease has a foundation in the gene-for-gene model, a model that hypothesizes that plants and pathogens have a molecular relationship with each other that mediates pathogenicity.  Today’s podcast features Drs. Lida Derevnina and Chih-Hang Wu, postdoctoral researchers with Sophien Kamoun (@KamounLab) at the Sainsbury Laboratory (@TheSainsburyLab) in Norwich, England.  They describe the new thinking of disease resistance as a number of complex layers that integrates many gene-for-gene interactions with other mechanisms in mediating plant defense.  Hosted by Paul Vincelli (@pvincell).This is a link to the article in Science. # COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

Dr. David Just studies human behavior and how psychology ties in with economic decisions.  His work at Cornell examines the interesting overlays that cause consumers to behave how they do.  In this podcast we examine consumer decisions in food, including a discussion about soft drinks, ketchup, meat, and ingredients from genetically engineered crops.  We also touch on the “GMO labeling” issue.Follow Dr. Just:   @DavidJust1 Also follow his podcast discussions at @MadHatEconomics And download here. # COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

Alfatoxins are a significant threat to human health and world food security.  They are naturally-occurring toxic compounds produced by the fungus Aspergillus flavus and other species.  These fungi thrive on corn, peanuts, wheat, rice and other food staples, and grow well in stored food supplies.  The compounds are potent carcinogens, and it is estimated that billions of people suffer from chronic exposure. Today’s guest is Dr. Peter Ojiambo from North Carolina State University.  He describes the current state of the problem and solutions, ranging from biocontrols, cultural adjustments and even modern biotechnology techniques.Dr. Ojiambo’s website 74 –Safer Foods with RNAi  (beating aflatoxin in maize with HIGS) 104 — Postharvest Solutions in Food Security 114 – Aflatoxin and Groundnut# COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

The 2016 World Food Prize went to a group that coordinated the breeding, promotion and distribution of the orange-fleshed sweet potato in Africa.  One of person on the team was economist Dr. Jan Low.  The sweet potato grows well in many parts of Africa.  It is not the sweet potato known to westerners.  It is white and dry, and more like bread than the well known Thanksgiving sweet potato.  At the same time there is widespread vitamin A deficiency, especially among children.  Could the orange sweet potato help solve a critical micronutrient deficiency?  Dr. Low and her team introduced the orange fleshed sweet potato to Africa, breeding them against locally adapted varieties.  The new potatoes were introduced with  marketing campaigns, helping introduce new populations to this novel product.  Soon, the orange fleshed sweet potato was aiding the diet, saving lives, and creating new entrepreneurial opportunities for African farmers and commerce.Follow Mark:   @JanLow1 www.sweetpotatoknowledge.org # COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.